Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Triamcinolone Paste to Reduce the Incidence of Postoperative Sore Throat

This study has been completed.
Information provided by:
Soonchunhyang University Hospital Identifier:
First received: May 21, 2009
Last updated: May 26, 2009
Last verified: May 2009
The purpose of this study is to determine whether triamcinolone paste applied over tracheal tube is effective to reduce the incidence of postoperative sore throat after tracheal intubation.

Condition Intervention
Tracheal Intubation
Drug: triamcinolone acetonide
Drug: chlorhexidine gluconate

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Triamcinolone Paste to Reduce the Incidence of Postoperative Sore Throat

Resource links provided by NLM:

Further study details as provided by Soonchunhyang University Hospital:

Primary Outcome Measures:
  • the incidence of postoperative sore throat [ Time Frame: postoperative day 1 ]

Secondary Outcome Measures:
  • the severity of postoperative sore throat [ Time Frame: postoperative day 1 ]

Enrollment: 150
Study Start Date: May 2008
Study Completion Date: May 2009
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: triamcinolone Drug: triamcinolone acetonide
paste applied over tracheal tube for lubrication
Placebo Comparator: chlorhexidine Drug: chlorhexidine gluconate
jelly applied over tracheal tube for lubrication

Detailed Description:
Sore throat is a common postoperative complaint after tracheal intubation. When the surgical pain is well controlled, sore throat is often the predominant complaint, therefore it is important to prevent sore throat.

Ages Eligible for Study:   20 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • ASA physical status I-II, aged between 20 and 70 years
  • scheduled for elective laparoscopic cholecystectomy under general anesthesia with endotracheal intubation

Exclusion Criteria:

  • recent respiratory tract infection or sore throat
  • who were using analgesics or steroid preoperatively
  • who have risk factors for oral cavity infection
  • the surgical duration < 60 minutes or > 300 minutes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00908817

Korea, Republic of
Soonchunhyang University, College of medicine Bucheon Hospital
1174 Jung-Dong, Wonmi-Gu, Bucheon-Si, Gyeonggi-Do, Korea, Republic of, 420-020
Sponsors and Collaborators
Soonchunhyang University Hospital
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Park Sun-Young, Soonchunhyang University, College of medicine Bucheon Hospital Identifier: NCT00908817     History of Changes
Other Study ID Numbers: ST
Study First Received: May 21, 2009
Last Updated: May 26, 2009

Keywords provided by Soonchunhyang University Hospital:
postoperative sore throat
tracheal intubation

Additional relevant MeSH terms:
Pharyngeal Diseases
Stomatognathic Diseases
Respiratory Tract Infections
Respiratory Tract Diseases
Otorhinolaryngologic Diseases
Chlorhexidine gluconate
Triamcinolone hexacetonide
Triamcinolone Acetonide
Triamcinolone diacetate
Anti-Infective Agents, Local
Anti-Infective Agents
Dermatologic Agents
Anti-Inflammatory Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Immunosuppressive Agents
Immunologic Factors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action processed this record on April 28, 2017